People (List)
-
Allen Burgenson
Global Subject Matter Expert, Associate Director, Lonza Walkersville, Inc.
-
Ursula Busse, PhD MBA
Regulatory Affairs IG Leader, Tigen Pharma
-
Renee Buthe
Renee has over seven years of industry experience, specifically with contamination control in cell and gene therapies. Renee holds a bachelor’s degree in biology with a minor in animal sciences. -
Lucy Cabral
Director, Genentech
-
Will Caffery
West Coast Regional Director, Benchmark Products
-
Carolina Camargo
Takeda
-
Mike Cammarata
STERIS Life Sciences
-
Cristiana Campa, PhD, GSK
GSK
Campa is currently a Technical R&D Advisor at GSK Vaccines, with more than 20 years of experience in chemistry, manufacturing and control (CMC) for biologics research and development. Campa current focus is on CMC advocacy, and she has contributed to several cross-company working groups. In this context, Campa is the European Federation of Pharmaceutical Industries and Associations lead in the ICH Working Group to revise ICH Q6 guidelines (specifications) and chair of the Vaccines Europe/ International Federation of Pharmaceutical Manufacturers and Associations. -
Javier Camposano, MBA
Javier is the Vice President of Drug Product Operations at Samsung Biologics, a global CDMO company based in South Korea. -
Anthony Cannon
-
Jose Caraballo
Kite Pharma
-
Heather Carr
Research Associate III, Baxter International Inc
-
Placeholder Person 3
CompanyName
Ratione laborum at aut harum iusto quaerat incidunt vero iste doloremque fugiat cumque nobis quis adipisci ipsum, molestiae sit error. Illum assumenda error sint veniam? Repellat sint sequi laudantium doloremque voluptatum atque rem soluta eaque ratione sit! Tempore quisquam ad magni aut dolores, at iste dolore eius nisi veniam molestiae quasi suscipit saepe sed facilis quae omnis perspiciatis -
Austin Caudle
Redica Systems
-
Lucia Ceresa
Charles River
-
Subrata Chakraborty
GxPfont Consulting Group
-
Chan Li Wei
Manager, Microbiology, MSD International GmbH
-
Christine Chan
Alpine Immune Sciences
-
K. Raghuram Chandra Rao
Asst Vice President – Quality, Gland Pharma Ltd
-
Andrew Chang, PhD
Novo Nordisk
Dr. Andrew Chang is a multifaceted quality and CMC leader with 25 years well-rounded medical product regulatory and industry experiences. He is the chair for PDA Biopharmaceutical Advisory Board (BioAB) and a board of director for CASSS-Sharing Science Solutions. At his current capacity as a Vice President, Quality and Regulatory Compliance, Regulatory Policy and Intelligence, Global Regulatory Affairs, Novo Nordisk, he provides strategic leadership on Regulatory and Quality related Policy, External Affairs, strategic advice and solutions to quality and regulatory related challenges.